Research shows that obesity causes cells in a brain region controlling blood pressure to age prematurely, triggering an overactive nervous system. In a study with obese mice, treatment with dasatinib and quercetin—drugs that remove aged cells—improved heart nervous system balance, suggesting a potential new approach to obesity-related heart problems. However, human studies are needed before this becomes a treatment option.
Researchers discovered that obesity causes cells in the brain to age prematurely, which makes the nervous system overactive and raises blood pressure. In a study with mice, scientists tested a combination of two drugs called dasatinib and quercetin that are designed to remove these aged cells. According to Gram Research analysis, the drug combination improved how well the heart’s nervous system balanced itself, suggesting a new way to treat heart problems linked to obesity. This finding could eventually lead to new treatments for people struggling with weight-related heart issues.
Key Statistics
A 2026 animal study published in GeroScience found that obese mice treated with dasatinib and quercetin showed improved cardiac autonomic balance as measured by heart rate variability, a key indicator of nervous system health.
Research showed that high-fat diet-fed mice developed increased DNA damage and cellular senescence markers in the RVLM brain region, a control center for blood pressure regulation, compared to normal-diet controls.
According to the 2026 study, senolytic drug treatment selectively improved heart nervous system flexibility in obese mice without changing overall blood pressure or global nervous system activity levels.
The Quick Take
- What they studied: Whether removing aged cells in a specific brain region could fix the overactive nervous system that causes high blood pressure in obese individuals
- Who participated: Male laboratory mice divided into two groups: one fed a normal diet and one fed a high-fat diet for 16 weeks to mimic obesity
- Key finding: Mice treated with dasatinib and quercetin showed improved heart nervous system balance, even though their blood pressure didn’t change
- What it means for you: This research suggests a potential new approach to treating heart problems in obese people, but human studies are needed before this becomes a real treatment option
The Research Details
Scientists fed mice a high-fat diet for 16 weeks to make them obese, similar to how humans gain weight. They then examined the mice’s brains and found that cells in a specific brain region called the RVLM (a control center for blood pressure and heart rate) had aged prematurely and accumulated damage. The researchers then gave some mice a combination of two drugs—dasatinib and quercetin—that are designed to eliminate these aged cells. They measured blood pressure using special monitors implanted in the mice and tracked heart rate patterns to assess nervous system activity.
The study used multiple methods to measure how active the nervous system was, including analyzing heart rate variability (the natural changes in time between heartbeats), measuring chemical signals in the blood, and testing how the heart responded to specific drugs. This multi-method approach gave researchers a complete picture of what was happening in the mice’s nervous systems.
Understanding what causes the nervous system to become overactive in obesity is crucial because this overactivity is a major reason why obese people develop high blood pressure and heart disease. By identifying that premature cell aging in the brain plays a role, researchers opened a new door to potential treatments that target this specific problem rather than just treating the symptoms.
This was a controlled laboratory study using mice, which allowed researchers to carefully control all variables and directly examine brain tissue. However, because it was done in mice rather than humans, results may not directly apply to people. The study was published in a peer-reviewed scientific journal, meaning other experts reviewed the work before publication. The researchers used multiple measurement methods, which strengthens confidence in their findings.
What the Results Show
Mice fed a high-fat diet developed obesity and showed signs of an overactive nervous system, including higher blood pressure and increased stress hormones. When researchers examined their brains, they found that cells in the RVLM region had aged prematurely and showed signs of DNA damage—similar to what happens when cells get old.
When the obese mice were treated with dasatinib and quercetin (drugs that remove aged cells), something interesting happened: their heart rate variability improved, meaning their nervous system became more balanced. Heart rate variability is an important sign of a healthy nervous system—it means the heart can adjust its rate appropriately to different situations.
Surprisingly, the drug treatment didn’t lower blood pressure or reduce overall nervous system activity in the way researchers initially expected. Instead, it specifically improved the balance and flexibility of the heart’s nervous system control, suggesting the drugs were working through a different mechanism than previously thought.
The study confirmed that obesity causes premature aging of cells in the brain region that controls blood pressure and heart rate. The researchers also found that this cellular aging was associated with increased inflammation and oxidative stress (cellular damage from harmful molecules). These findings suggest that cellular aging is an important but previously overlooked mechanism linking obesity to heart problems.
Previous research showed that obesity causes an overactive nervous system, but scientists didn’t fully understand why. This study adds an important piece to the puzzle by identifying premature cell aging as a contributing factor. The finding that removing aged cells improved nervous system balance (but not blood pressure) suggests that cellular aging affects how the nervous system functions in ways that are separate from blood pressure control, which is a new insight.
This study was conducted in mice, not humans, so the results may not directly translate to people. The sample size of mice wasn’t specified in the available information. The drug combination improved some measures of nervous system function but didn’t lower blood pressure, which raises questions about how effective this approach might be for treating obesity-related heart disease in humans. Additionally, the study only looked at male mice, so results might differ in females. More research is needed to determine if these findings apply to people and whether the drugs would be safe and effective as a treatment.
The Bottom Line
This research is still in the early stages (animal studies only), so it’s not yet ready to be used as a treatment for people. However, it suggests that drugs targeting cellular aging could become part of obesity treatment in the future. For now, proven approaches like weight loss through diet and exercise remain the best ways to reduce obesity-related heart problems. Moderate confidence in this finding due to animal-only studies.
People with obesity who are concerned about heart health should pay attention to this research as it develops. Healthcare providers treating obesity-related heart problems may eventually benefit from this new understanding. People interested in aging and longevity science should find this relevant. However, this research is not yet applicable to individual treatment decisions.
This is basic research that may take 5-10 years or more to develop into human treatments. Clinical trials in humans would need to happen before any new drug could be prescribed. In the meantime, people with obesity should focus on proven strategies like weight loss, exercise, and working with their doctors.
Frequently Asked Questions
Can dasatinib and quercetin treat obesity-related high blood pressure in humans?
Not yet. This 2026 study was conducted only in mice. While results are promising, human clinical trials are needed to determine if these drugs are safe and effective for people. Current proven treatments include weight loss, exercise, and medications prescribed by doctors.
What is cellular senescence and why does obesity cause it?
Cellular senescence is when cells age prematurely and stop dividing but don’t die—they accumulate in tissues and cause problems. Obesity triggers this through oxidative stress and inflammation in the brain regions controlling blood pressure, though the exact mechanisms are still being studied.
How does heart rate variability relate to nervous system health?
Heart rate variability measures natural changes in time between heartbeats. Higher variability indicates a flexible, healthy nervous system that can adapt to different situations. Lower variability suggests the nervous system is stuck in an overactive state, which increases disease risk.
When will this research lead to treatments for people with obesity?
This is early-stage research. Typically, animal studies take 5-10 years before human clinical trials begin. If trials are successful, regulatory approval could take several more years. Proven weight loss strategies remain the best current approach.
Does this research apply to people who are overweight but not obese?
This study specifically examined obese mice, so results may not directly apply to overweight individuals. The mechanisms causing nervous system problems may differ at different weight levels, requiring separate research to determine.
Want to Apply This Research?
- Track heart rate variability during rest using a wearable device or smartphone app. Measure your resting heart rate each morning before getting out of bed and note any patterns over weeks and months as you work on weight management.
- Use the app to set and monitor weight loss goals through diet and exercise, which are proven ways to improve the nervous system balance that this research identified as important. Log daily physical activity and meals to stay accountable.
- Over 8-12 weeks, track changes in resting heart rate, heart rate variability, and weight. These metrics reflect the nervous system balance that the research showed is important for heart health in people with obesity.
This research was conducted in laboratory mice and has not been tested in humans. The findings are preliminary and should not be interpreted as medical advice or a basis for treatment decisions. People with obesity or high blood pressure should consult their healthcare provider about proven treatment options including weight loss, exercise, and medications. Do not take dasatinib, quercetin, or any other medication without explicit direction from a qualified healthcare provider. This article is for educational purposes only and does not replace professional medical guidance.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.